Different groups have likely shown an increased percentage of CD8+ T cells with a senescent phenotype (CD28−CD57+INFγhigh TNFαhigh) in AML-affected patients compared to age-matched healthy donors. The gene discussed is CD8A; the disease is acute myeloid leukemia.